Clinical Trials Logo
  1. Home
  2. Adult ALL
  3. NCT04819854

Single and Multiple Ascending Dose Study With EP395

Adult ALL Clinical Trial

Official title:
A First-in Man, Phase I Study Investigating the Safety and Tolerability of EP395 in Healthy Volunteers

Clinical Trial Summary

This is a study to asses the safety and tolerability of single and multiple ascending doses of EP395, administered by oral capsules, in healthy subjects with the aim to determine the safe dose range of EP395 for further clinical development

Clinical Trial Description

This is a study to asses the safety and tolerability of single and multiple ascending doses of EP395, administered by oral capsules, in healthy subjects with the aim to determine the safe dose range of EP395 for further clinical development. The study consists of two parts, part A where single-ascending doses will be assessed and part B where multiple-ascending doses will be assessed. The primary objective being safety and tolerability as well as the pharmacokinetic properties of EP395. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04819854
Study type Interventional
Source EpiEndo Pharmaceuticals
Contact
Status Completed
Phase Phase 1
Start date April 5, 2021
Completion date March 22, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT05849792 - Internet-based Physical Activities Randomized Controlled Trial in Mild/Moderate Depression Participants: SONRIE Project N/A
Completed NCT06110702 - Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms N/A
Recruiting NCT05505864 - Assessing Sedentary Behaviour in Adults With Type 2 Diabetes - A Randomized Controlled Trial N/A
Completed NCT05209360 - Heel Wedges and Carbon Fiber Custom Dynamic Orthoses to Control Knee Biomechanics N/A
Not yet recruiting NCT04646304 - Motion Capture as a Tool for the Assessment of Laparoscopic Performance N/A
Completed NCT04806100 - Effects of Malleo-Lok Stiffness on Lower Limb Mechanics N/A
Terminated NCT05361356 - Spectral CT Clinical Trial N/A
Completed NCT05642988 - Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period
Completed NCT05090956 - Developpement of 3T MRI Protocol N/A
Completed NCT05845827 - Dietary Impact on Continuous Glucose Monitoring
Not yet recruiting NCT05340985 - Investigating the Effects of Hydroxyvitamin D3 on Multiple Sclerosis Phase 4
Completed NCT05711602 - The Physical and Mental Health of People With Type II Diabetes Mellitus. N/A
Recruiting NCT04755478 - LUS to Assess Lung Injury After Lung Lobectomy
Completed NCT05560412 - Zein Nanoparticles for Glycemic Control N/A
Not yet recruiting NCT05206903 - Emotional and Physical Health Status of Adults
Recruiting NCT06220487 - A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL Phase 2
Not yet recruiting NCT06175702 - Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL
Recruiting NCT04677309 - LUS to Assess Lung Injury After Lung Resection
Completed NCT04800510 - Iterative Design of Custom Dynamic Orthoses N/A
Recruiting NCT06386861 - Validating the Spanish "Attitudes Toward Genomics and Precision Medicine" (AGPM). N/A